Articles publiés

General hospital admissions in young and middle-aged people who use psychoactive substances: Impact of Covid-19 lockdowns.

Perino J, Ramaroson H, Ong N, Bezin J, Gilleron V, Daveluy A, Tournier M. General hospital admissions in young and middle-aged people who use psychoactive substances: Impact of Covid-19 lockdowns. Int J Drug Policy. 2023 Jun 8;118:104082. doi: 10.1016/j.drugpo.2023.104082. Epub ahead of print. PMID: 37336071; PMCID: PMC10247883.

Prévention des surdoses opioïdes et diffusion de naloxone (programme POP) : résultats d’un état des lieux réalisé auprès des structures d’addictologie

Mezaache S, Turlure F, Fredon N, Le Brun Gadelius M, Micallef J, Frauger E. Prévention des surdoses opioïdes et diffusion de naloxone (programme POP) : résultats d’un état des lieux réalisé auprès des structures d’addictologie [Opioid overdose prevention and naloxone diffusion (POP program): Results of an overview conducted among addiction specialized centres]. Therapie. 2023 Mar 15:S0040-5957(23)00057-4. French. …

Prévention des surdoses opioïdes et diffusion de naloxone (programme POP) : résultats d’un état des lieux réalisé auprès des structures d’addictologie Lire la suite »

French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change.

Aquizerate A, Laforgue EJ, Istvan M, Rousselet M, Gerardin M, Jouanjus E, Libert F; French Addictovigilance Network; Guerlais M, Victorri-Vigneau C. French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change. Eur J Public Health. 2023 Feb 7:ckad003. doi: 10.1093/eurpub/ckad003. Epub ahead of print. …

French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change. Lire la suite »

Chemsex in HIV pre-exposure prophylaxis users: Assessment of mood disorders and addictive behavior.

Peyriere H, Jacquet JM, Peries M, Tribout V, Broche B, Mauboussin JM, Makinson A, Perrollaz C, Ferreyra M, Rouanet I, Montoya-Ferrer A, El-Majjaoui S, Corriol-Bonifas F, Fraisse T, Grau F, Laureillard D, Nagot N, Reynes J, Donnadieu-Rigole H. Chemsex in HIV pre-exposure prophylaxis users: Assessment of mood disorders and addictive behavior. Fundam Clin Pharmacol. 2022 Nov 20. …

Chemsex in HIV pre-exposure prophylaxis users: Assessment of mood disorders and addictive behavior. Lire la suite »

Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey

Blayac L, Ponte C, Lavaud M, Micallef J, Lapeyre-Mestre M. Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey. Therapie. 2022 Oct 8:S0040-5957(22)00171-8. doi: 10.1016/j.therap.2022.10.003. Epub ahead of print. PMID: 36283856.

Retour en haut